Aptamer Group reports strong FY2025 growth and expands Optimer® portfolio

Aptamer Group plc (LON:APTA), the leading developer of next-generation synthetic binders delivering innovation to the life science industry, has announced that the Annual Report and Accounts for the year ended 30 June 2025 and Notice of its 2025 Annual General Meeting (AGM) were posted to shareholders today.

APTA-Annual-Report-2025 Download

Aptamer will host its AGM at 11:00 GMT on 27 November 2025 at Windmill House, Innovation Way, York, YO10 5BR. The AGM will be held in person only and there will be no new information presented at the meeting.

The results of voting on all resolutions at the AGM will be announced to the London Stock Exchange and the full results of the voting published on the Company’s website, as soon as practicable after the conclusion of the AGM.

Share on:

You might also enjoy reading Aptamer Group secures £360,000 contract with top 3 global pharma

Written by: Amilia Stone

Latest Company News

Aptamer Group secures £270k in new orders and first cash licensing receipts

January 29, 2026

Aptamer Group plc has announced £190,000 in new fee-for-service Optimer® orders and £80,000 in cash licensing receipts, including its first payment from a hot-start PCR licence.

Aptamer reports 27% revenue growth and signs multiple licensing deals in H1 FY26

January 7, 2026

Aptamer Group reported unaudited revenue of £0.83 million for the six months to 31 December 2025, a 27% increase year on year, supported by strong fee-for-service demand and the signing of multiple licensing agreements.

Aptamer Group signs first licensing deal with Twist Bioscience

December 16, 2025

Aptamer Group has entered into its first licensing agreement with Twist Bioscience, granting a non-exclusive licence for the use of an Optimer® binder in hot-start PCR and next-generation sequencing products.